A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

NCT02206152 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Hypoglycemia Unawareness

Interventions

DRUG: N-acetyl cysteine
DRUG: Placebo

Sponsor

University of Minnesota